Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBT (2016 - 2025)

Innoviva's EBT history spans 16 years, with the latest figure at $97.8 million for Q3 2025.

  • For Q3 2025, EBT rose 1328.19% year-over-year to $97.8 million; the TTM value through Sep 2025 reached $121.3 million, up 1883.11%, while the annual FY2025 figure was $326.9 million, 774.85% up from the prior year.
  • EBT reached $97.8 million in Q3 2025 per INVA's latest filing, up from $72.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $286.4 million in Q3 2022 to a low of -$39.3 million in Q2 2024.
  • Average EBT over 5 years is $51.8 million, with a median of $41.1 million recorded in 2023.
  • Peak YoY movement for EBT: crashed 776.64% in 2024, then skyrocketed 1328.19% in 2025.
  • A 5-year view of EBT shows it stood at -$6.0 million in 2021, then tumbled by 70.77% to -$10.3 million in 2022, then soared by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then soared by 1028.14% to $97.8 million in 2025.
  • Per Business Quant, the three most recent readings for INVA's EBT are $97.8 million (Q3 2025), $72.6 million (Q2 2025), and -$38.6 million (Q1 2025).